Copyright Reports & Markets. All rights reserved.

Global Antibody-drug Conjugates Market Professional Survey Report 2019

Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Antibody-drug Conjugates

      • 1.1 Definition of Antibody-drug Conjugates
      • 1.2 Antibody-drug Conjugates Segment by Type
        • 1.2.1 Global Antibody-drug Conjugates Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Adcetris
        • 1.2.3 Kadcyla
      • 1.3 Antibody-drug Conjugates Segment by Applications
        • 1.3.1 Global Antibody-drug Conjugates Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Breast Cancer
        • 1.3.3 Lymphoma
      • 1.4 Global Antibody-drug Conjugates Overall Market
        • 1.4.1 Global Antibody-drug Conjugates Revenue (2014-2025)
        • 1.4.2 Global Antibody-drug Conjugates Production (2014-2025)
        • 1.4.3 North America Antibody-drug Conjugates Status and Prospect (2014-2025)
        • 1.4.4 Europe Antibody-drug Conjugates Status and Prospect (2014-2025)
        • 1.4.5 China Antibody-drug Conjugates Status and Prospect (2014-2025)
        • 1.4.6 Japan Antibody-drug Conjugates Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Antibody-drug Conjugates Status and Prospect (2014-2025)
        • 1.4.8 India Antibody-drug Conjugates Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Antibody-drug Conjugates
      • 2.3 Manufacturing Process Analysis of Antibody-drug Conjugates
      • 2.4 Industry Chain Structure of Antibody-drug Conjugates

      3 Development and Manufacturing Plants Analysis of Antibody-drug Conjugates

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Antibody-drug Conjugates Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Antibody-drug Conjugates
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Antibody-drug Conjugates Production and Capacity Analysis
      • 4.2 Antibody-drug Conjugates Revenue Analysis
      • 4.3 Antibody-drug Conjugates Price Analysis
      • 4.4 Market Concentration Degree

      5 Antibody-drug Conjugates Regional Market Analysis

      • 5.1 Antibody-drug Conjugates Production by Regions
        • 5.1.1 Global Antibody-drug Conjugates Production by Regions
        • 5.1.2 Global Antibody-drug Conjugates Revenue by Regions
      • 5.2 Antibody-drug Conjugates Consumption by Regions
      • 5.3 North America Antibody-drug Conjugates Market Analysis
        • 5.3.1 North America Antibody-drug Conjugates Production
        • 5.3.2 North America Antibody-drug Conjugates Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Antibody-drug Conjugates Import and Export
      • 5.4 Europe Antibody-drug Conjugates Market Analysis
        • 5.4.1 Europe Antibody-drug Conjugates Production
        • 5.4.2 Europe Antibody-drug Conjugates Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Antibody-drug Conjugates Import and Export
      • 5.5 China Antibody-drug Conjugates Market Analysis
        • 5.5.1 China Antibody-drug Conjugates Production
        • 5.5.2 China Antibody-drug Conjugates Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Antibody-drug Conjugates Import and Export
      • 5.6 Japan Antibody-drug Conjugates Market Analysis
        • 5.6.1 Japan Antibody-drug Conjugates Production
        • 5.6.2 Japan Antibody-drug Conjugates Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Antibody-drug Conjugates Import and Export
      • 5.7 Southeast Asia Antibody-drug Conjugates Market Analysis
        • 5.7.1 Southeast Asia Antibody-drug Conjugates Production
        • 5.7.2 Southeast Asia Antibody-drug Conjugates Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Antibody-drug Conjugates Import and Export
      • 5.8 India Antibody-drug Conjugates Market Analysis
        • 5.8.1 India Antibody-drug Conjugates Production
        • 5.8.2 India Antibody-drug Conjugates Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Antibody-drug Conjugates Import and Export

      6 Antibody-drug Conjugates Segment Market Analysis (by Type)

      • 6.1 Global Antibody-drug Conjugates Production by Type
      • 6.2 Global Antibody-drug Conjugates Revenue by Type
      • 6.3 Antibody-drug Conjugates Price by Type

      7 Antibody-drug Conjugates Segment Market Analysis (by Application)

      • 7.1 Global Antibody-drug Conjugates Consumption by Application
      • 7.2 Global Antibody-drug Conjugates Consumption Market Share by Application (2014-2019)

      8 Antibody-drug Conjugates Major Manufacturers Analysis

      • 8.1 ImmunoGen
        • 8.1.1 ImmunoGen Antibody-drug Conjugates Production Sites and Area Served
        • 8.1.2 ImmunoGen Product Introduction, Application and Specification
        • 8.1.3 ImmunoGen Antibody-drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Seattle Genetics
        • 8.2.1 Seattle Genetics Antibody-drug Conjugates Production Sites and Area Served
        • 8.2.2 Seattle Genetics Product Introduction, Application and Specification
        • 8.2.3 Seattle Genetics Antibody-drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Roche
        • 8.3.1 Roche Antibody-drug Conjugates Production Sites and Area Served
        • 8.3.2 Roche Product Introduction, Application and Specification
        • 8.3.3 Roche Antibody-drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Takeda
        • 8.4.1 Takeda Antibody-drug Conjugates Production Sites and Area Served
        • 8.4.2 Takeda Product Introduction, Application and Specification
        • 8.4.3 Takeda Antibody-drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served

      9 Development Trend of Analysis of Antibody-drug Conjugates Market

      • 9.1 Global Antibody-drug Conjugates Market Trend Analysis
        • 9.1.1 Global Antibody-drug Conjugates Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Antibody-drug Conjugates Regional Market Trend
        • 9.2.1 North America Antibody-drug Conjugates Forecast 2019-2025
        • 9.2.2 Europe Antibody-drug Conjugates Forecast 2019-2025
        • 9.2.3 China Antibody-drug Conjugates Forecast 2019-2025
        • 9.2.4 Japan Antibody-drug Conjugates Forecast 2019-2025
        • 9.2.5 Southeast Asia Antibody-drug Conjugates Forecast 2019-2025
        • 9.2.6 India Antibody-drug Conjugates Forecast 2019-2025
      • 9.3 Antibody-drug Conjugates Market Trend (Product Type)
      • 9.4 Antibody-drug Conjugates Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Antibody-drug Conjugates Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Antibody-drug Conjugates market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Antibody-drug Conjugates volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antibody-drug Conjugates market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Antibody-drug Conjugates in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Antibody-drug Conjugates manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        ImmunoGen
        Seattle Genetics
        Roche
        Takeda
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Adcetris
        Kadcyla

        Segment by Application
        Breast Cancer
        Lymphoma

        Buy now